---

Recent Advances in Glaucoma Treatment

---

Summary of Key Themes

1. Medical therapy is shifting from daily drops toward sustained-release intracameral implants (iDose TR, Durysta, ENV515) to address the chronic adherence problem.
2. SLT is now an evidence-based first-line therapy, not a second-line rescue procedure, following LiGHT and GLAUrious trial data.
3. MIGS has expanded beyond Schlemm's canal to supraciliary and subconjunctival targets, with longer follow-up data now available for many devices.
4. Neuroprotection - protecting retinal ganglion cells independent of IOP - is the biggest frontier, with CNTF implants, gene therapy (astrocyte modulation), and RGC regeneration strategies moving from bench to early clinical trials.
5. AI and genetics are beginning to personalize screening, diagnosis, and treatment planning.

---

Role of Artificial Intelligence in Ophthalmology

Short Note for PG Ophthalmology Exam

---

Definition & Types of AI Used

• Machine Learning (ML) - algorithms that learn from labelled data
• Deep Learning (DL) - subset of ML using convolutional neural networks (CNNs); best for image analysis
• Large Language Models (LLMs) - used for clinical text processing, report generation, patient communication

---

Why Ophthalmology is Ideal for AI

1. Ophthalmology is predominantly image-based (fundus photos, OCT, slit-lamp images, visual fields, corneal topography)
2. Large validated datasets exist for training
3. Many diseases have well-defined morphological features amenable to pattern recognition
4. High burden of preventable blindness makes screening a priority
5. The retina is a "window to systemic disease" - AI can detect cardiovascular risk, renal disease, and neurodegenerative conditions from fundus images

---

Applications by Subspecialty

1. Retina (Most Advanced Area)

Exam Point: IDx-DR / LumineticsCore was the first FDA-cleared autonomous (no ophthalmologist required) AI diagnostic system - approved 2018 for DR screening.

---

2. Glaucoma

• Optic disc analysis from fundus photos - detection of cupping, RNFL defects, rim thinning
• OCT RNFL progression - AI detects structural changes earlier than visual field loss
• Visual field (VF) interpretation - pattern recognition for glaucomatous VF defects; prediction of VF loss from structural data
• EHR-based risk stratification - predicting patients at high risk before clinical signs appear
• AI for surgical outcome prediction (trabeculectomy, MIGS) using neural networks
• Challenge: No FDA-cleared autonomous glaucoma AI yet (unlike DR); current tools are decision-support only

---

3. Anterior Segment & Cornea

• Keratoconus detection - AI on corneal topography/tomography (Pentacam-based algorithms) with high sensitivity for subclinical cases
• Cataract grading - automated LOCS scoring from slit-lamp images
• IOL power calculation - AI-based formulas (Hill-RBF, Kane formula) outperform traditional regression formulas (SRK/T) in post-refractive and short/long axial length eyes
• Infectious keratitis classification - bacterial vs. fungal vs. acanthamoeba on slit-lamp images

Exam Point: AI-based IOL formulas (Hill-RBF, Kane) are now preferred over traditional formulas (Haigis, Hoffer Q, SRK/T) in complex eyes.

---

4. Retinopathy of Prematurity (ROP)

• i-RET, KIDROP - AI-based telemedicine screening for ROP in NICUs
• Detects plus disease and stage classification from retinal photographs
• Particularly relevant for low-resource settings with limited pediatric ophthalmologists
• i-RET approved in India; validated against expert grading

Exam Point: ROP AI screening is highly relevant in India due to shortage of trained ROP screeners in tier-2/3 hospitals.

---

5. Pediatric Ophthalmology

• Amblyopia / strabismus screening - automated photoscreeners using AI for red reflex analysis and strabismus detection
• Refractive error detection in children using smartphone-based apps

---

6. Neuro-ophthalmology

• Papilledema detection from fundus photos
• Optic neuritis vs. other optic neuropathies - AI on OCT and VEP data
• Systemic neurological risk prediction from retinal vasculature (Alzheimer's, MS, Parkinson's)

---

7. Ocular Oncology

• Choroidal melanoma vs. nevus - ML prediction of malignant transformation risk
• Retinoblastoma - detection from red reflex photographs in infants

---

8. Systemic Disease Prediction from Retinal Images

• Cardiovascular risk (age, sex, blood pressure, HbA1c predicted from fundus)
• Chronic kidney disease biomarkers
• Anaemia detection
• Neurodegenerative disease biomarkers (Alzheimer's amyloid from retinal images - active research)

---

Regulatory Milestones

---

Limitations of AI in Ophthalmology

1. Dataset bias - most training data from Western/high-income populations; performance gap in South Asian, African populations
2. "Black box" problem - explainability (XAI) is limited; clinicians cannot always understand the AI decision
3. Regulatory lag - approval processes slow relative to rapid AI development
4. Equity concerns - AI fairness across race/ethnicity/sex is an active concern (especially in glaucoma models)
5. Overfitting - AI may perform well in training data but fail in real-world settings (different cameras, ethnicities, co-morbidities)
6. Rare diseases - insufficient training data for uncommon conditions
7. No replacement for clinical judgment - AI is a decision-support tool, not a substitute for the ophthalmologist

---

Key Exam Points (High Yield)

---

Recent Developments (2024-2026)

• Foundation models and LLMs (GPT-4, Med-PaLM) being tested for ophthalmic clinical notes, report generation, and patient education
• Vision-language foundation models for multimodal (image + text) ophthalmic diagnosis - systematic reviews published 2025
• AI-assisted surgical video analysis for cataract and vitreoretinal surgery - automated step recognition, complication detection
• AI-guided teleophthalmology in resource-limited settings for mass screening programs

---